Research and Development is at the center of everything we do, it is the heart of our business It does not only drives our work today, but it fosters the work we will do tomorrow, enabling us to develop innovative therapies that will help millions of more people.
Innovation has always been one of the key ingredients of BPI’s success. BPI has developed a unit to control every aspect of the production chain beginning with research in manufacturing to products’ delivery. BPI has upgraded its Research and Development (R&D) unit to offer a cGMP certified Pilot Plant capable of developing, formulating, manufacturing, packaging, and analyzing pharmaceutical products.
A Team of Experienced Professionals
Combining creativity, scientific rigor and our extensive knowledge on a broad range of PhD and Medical doctors, pharmacists, scientists, engineers, product leaders and Executive officers across the country use their expertise to innovate novel biologics, biosimilars, small molecule specialty medicines, generics over-the-counter therapies and news and innovative cell therapy technology.
A STATE OF THE ART PILOT PLANT FACILITY
The R&D unit and cGMP Pilot Plant respond to the growing market demands and challenge unmet medical needs in order to improve people’s well-being.
The unit accommodates a wide range of cutting-edge equipment, a centralized quality control laboratory, and stability chambers for the delivery of high-quality products.
A Modern Generic Pipeline
BPI has been collaborating with leading international scientific corporations, industrial research institutes, and prestigious universities for pipeline expansion and strategic development.
Our R&D unit is currently handling a wide pipeline of oral dosage forms that include granules, capsules, and tablets.